We have located links that may give you full text access.
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis.
Journal of Biological Chemistry 2018 September 29
Sulfated glycans are known to be involved in several glycan-mediated cell adhesion and recognition pathways. Our mRNA transcript analyses on the genes involved in synthesizing GlcNAc-6- O -sulfated glycans in human colon cancer tissues indicated that GlcNAc6ST-2 ( CHST4 ) is preferentially expressed in cancer cells compared with nonmalignant epithelial cells among the three known major GlcNAc-6- O -sulfotransferases. On the contrary, GlcNAc6ST-3 ( CHST5 ) was only expressed in nonmalignant epithelial cells, whereas GlcNAc6ST-1 ( CHST2 ) was expressed equally in both cancerous and nonmalignant epithelial cells. These results suggest that 6- O -sulfated glycans that are synthesized only by GlcNAc6ST-2 may be highly colon cancer-specific, as supported by immunohistochemical staining of cancer cells using the MECA-79 antibody known to be relatively specific to the enzymatic reaction products of GlcNAc6ST-2. By more precise MS-based sulfoglycomic analyses, we sought to further infer the substrate specificities of GlcNAc6STs via a definitive mapping of various sulfo-glycotopes and O -glycan structures expressed in response to overexpression of transfected GlcNAc6STs in the SW480 colon cancer cell line. By detailed MS/MS sequencing, GlcNAc6ST-3 was shown to preferentially add sulfate onto core 2-based O -glycan structures, but it does not act on extended core 1 structures, whereas GlcNAc6ST-1 prefers core 2-based O -glycans to extended core 1 structures. In contrast, GlcNAc6ST-2 could efficiently add sulfate onto both extended core 1- and core 2-based O -glycans, leading to the production of unique sulfated extended core 1 structures such as R-GlcNAc(6-SO3 - )β1-3Galβ1-4GlcNAc(6-SO3 - )β1-3Galβ1-3GalNAcα, which are good candidates to be targeted as cancer-specific glycans.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app